PARLIAMENTARY WRITTEN QUESTION
(16 January 2025)

To ask the Secretary of State for Health and Social Care, whether he plans to issue new guidance on the use of (a) Novarapid, (b) Insulin flextouch, (c) Insulatard and (d) Levimir for diabetes patients before March 2025.

Asked by:
Tristan Osborne (Labour)

In late 2024, the Department issued communications on the discontinuation of both Novorapid Flextouch and Insulatard Penfill cartridges to the National Health Service, advising on suitable alternatives. The Department is working with NHS England and clinical experts to develop management advice for healthcare professionals ahead of the discontinuation of Levemir, in December 2026. This will be communicated at the earliest opportunity. There are no plans to issue guidance on Insulin Flextouch.

Answered by:
()